BioShares Biotechnology Products Fund ETF News

This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ

Here’s something to take some of the sting out of hard investing decisions. I call it the 3 Cs of trading in a crisis. Capital. Conviction. Courage. In order to

Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to

US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric

EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance

Increasing M&A; deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby

The Medicines Company climbed to an all-time high Tuesday after takeover rumors surfaced. Play the momentum using these tactical ideas.

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.